Brownstein Hyatt Farber Schreck Obo Caredx, INC.
Molecular diagnostics
Based in CA
AI Overview
With $0 in lobbying spend across 11 quarterly filings, Brownstein Hyatt Farber Schreck Obo Caredx, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Brownstein Hyatt Farber Schreck Obo Caredx, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Immuno suppressant legislation
Immunosuppressant legislation
Immunosuppressant Legislation; education regarding CareDxs suite of Immunosuppressant products and services
Use of bioscience markers with regard to organ transplant rejection
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.